Los puntos clave no están disponibles para este artículo en este momento.
This Viewpoint from the US Preventive Services Task Force (USPSTF) introduces their 2017 draft recommendation statement on screening for prostate cancer, explains how it differs from their 2012 recommendation, and invites public comment.
Bibbins‐Domingo et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: